Tag:
Natco Pharma
Latest Headlines
Latest Headlines
Bayer slams Indian government, Cipla on Nexavar copies
Since the Indian government yanked its exclusivity on the cancer drug, the German company is fighting back.
Copaxone patent fight set for court Sept. 7
You can't accuse Teva Pharmaceutical Industries ( $TEVA ) of leaving its multiple sclerosis blockbuster Copaxone unprotected. The Israeli company, which has been fighting off generics challenges in
Natco wants OK to copy patented Pfizer HIV drug
India's Natco Pharma has big plans for a Pfizer HIV drug--provided the world's largest drugmaker plays along. Natco has taken the first step toward a compulsory license on Selzentry (maraviroc), by
